Randomized Phase II Trial of Letrozole plus Anti-MUC1 Antibody AS1402 in Hormone Receptor–Positive Locally Advanced or Metastatic Breast Cancer-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Randomized Phase II Trial of Letrozole plus Anti-MUC1 Antibody AS1402 in Hormone Receptor–Positive Locally Advanced or Metastatic Breast Cancer

Published:2011-08-30 Issue:21 Volume:17 Page:6822-6830
ISSN:1078-0432
Container-title:Clinical Cancer Research
language:en
Short-container-title:Clin Cancer Res

Author:

Ibrahim Nuhad K.,Yariz Kemal O.,Bondarenko Ihor,Manikhas Alexei,Semiglazov Vladimir,Alyasova Anna,Komisarenko Volodymyr,Shparyk Yaroslav,Murray James Lee,Jones David,Senderovich Shai,Chau Albert,Erlandsson Fredrik,Acton Gary,Pegram Mark

Publisher

American Association for Cancer Research (AACR)

Subject

Cancer Research,Oncology

Cited by 61 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Mucin1 as a potential molecule for cancer immunotherapy and targeted therapy;Journal of Cancer;2024

2. Suppression of MUC1-Overexpressing Tumors by a Novel MUC1/CD3 Bispecific Antibody;Antibodies;2023-07-13

3. Advances in PET/CT Imaging for Breast Cancer;Journal of Clinical Medicine;2023-07-07

4. Antitumor effect of a novel humanized MUC1 antibody-drug conjugate on triple-negative breast cancer;Heliyon;2023-04

5. Endocrine Therapy-Based Strategies for Metastatic Breast Cancer with Different Endocrine Sensitivity Statuses: A Systematic Review and Network Meta-Analysis;Cancers;2022-12-11

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP